Table 2.
Clinical parameters | Cases (n = 60) | MBNL1‐AS1 expression level | P value | |
---|---|---|---|---|
Low | High | |||
Gender | .64043 | |||
Male | 55 | 28 | 27 | |
Female | 5 | 2 | 3 | |
Age | .59816 | |||
<60 | 24 | 13 | 11 | |
≥60 | 36 | 17 | 19 | |
T stage | .01952* | |||
T1/T2 | 44 | 18 | 26 | |
T3/T4 | 16 | 12 | 4 | |
Histopathological grade | .31324 | |||
G1 | 1 | 0 | 1 | |
G2‐G3 | 59 | 30 | 29 | |
Tumor size | .03843* | |||
<3cm | 28 | 10 | 18 | |
≥3 cm | 32 | 20 | 12 | |
Tumor number | .02846* | |||
Unifocal | 40 | 16 | 24 | |
Multifocal | 20 | 14 | 6 |
Abbreviations: BC, bladder cancer; MBNL1‐AS1, muscleblind‐like 1 antisense RNA 1.
The P values had statistically significant differences (P < .05).